Observation

Det var ett tag sen jag var inne på PHI`s hemsida över befintliga kunder. Ser idag att listan över dessa expanderat ganska mycket.En hel del nya namn jag inte sett tidigare.På rak arm hittar jag drygt 30 nya namn jag inte känner igen sen tidigare.Glädjande är utvecklingen i USA och Kina.Bolagets största marknader.Sen har nya länder tillkommit som ex Belgien, Holland,Kanada och Nya Zeeland.

Sen ser jag att vi fått in 2 nya Svenska företag på listan. Fluicell som satsar stort på Regenerativ medicin och cancerforskningsföretaget Cline. Just Cline förutspådde bloggen i Dec 2021 skulle offentliggöras som HoloMonitoranvändare. Länk. Jag fick alltså rätt i det.

"Att intressanta cancerforskningsföretaget Cline  efter ha kommit så långt i sitt forskningsprojekt behöver använda sig av ny teknik känns ganska naturligt.Att det handlar om HoloMonitor är jag som sagt ganska säker på,men en verifikation hade naturligtvis varit bra.Kanske vi får det i den kommande rapporten?"

Med denna nya lista kanske vi inte ska dra slutsatsen att det går så knackigt för Bolaget rent försäljningsmässigt?

Noterbart ytterligare är att anrika Johns Hopkins University anslutit sig till kända amerikanska universitet att använda HoloMonitor i sin forskning. Grundat 1876 och först i USA att satsa stort på forskning.Rankas som 12e bäst i världen bland alla lärosäten. De övriga kända unisen från USA är naturligtvis främst Harvard och Stanford. Jag kan tycka att PHI är lite väl blyga att berätta att de fått in ett av världens mest förnäma universitet som användare. Johns Hopkins är ingen småspelare.

Jag kopierar hela listan så kan man se om/när det tillkommer nya namn.

Hursom,det händer saker rent försäljningsmässigt. Icke att ta miste på.

AUSTRALIA

• Monash University, Melbourne
• Bosch Institute, University of Sydney, Sydney
• The Science Place, James Cook University, Townsville
• QIMR Berghofer Medical Research Institute, Brisbane
• Menzies Health Institute, Griffith University, Gold Coast
• Vascular Biology Unit, James Cook University, Townsville
• Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane
• Queensland Centre for Drug Target Screening and Characterisation, Queensland University of Technology, Brisbane

BELGIUM

• IRIBHM, Université Libre de Bruxelles

CANADA

• Bluerock Therapeutics, Toronto
• Cardiovascular Research Centre, University of Alberta, Edmonton

CHINA

• Institute of Pharmacy, Henan University, Kaifeng
• Biosafety Level 3 Laboratory, Southern Medical University, Guangzhou
• Department of Immunology, The Fourth Military Medical University, Xi’an
• State Key Laboratory of Proteomics, Institute of Radiation Medicine, Beijing
• Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai
• Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing
• Institute of Biomechanics and Medical Engineering, Tsinghua University, Beijing
• School of Resources and Environment, Northeast Agricultural University, Harbin
• Laboratory of Molecular Iron Metabolism, Hebei Normal University, Shijiazhuang
• State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi
• Department of Neurology, First Hospital of Hebei Medical University, Shijiazhuang
• The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing
• Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang
• The Affiliated Stomatologic Hospital, School of Medicine, Zhejiang University, Hangzhou
• State Key Laboratory of Brain and Cognitive Science, Chinese Academy of Sciences, Beijing
• Department of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang
• Tianjin Key Laboratory of Neurotrauma Repair, University of Chinese People’s Armed Police Force, Tianjin
• Molecular Medicine Research Center, Sichuan University and Collaborative Innovation Center, Chengdu
• School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou
• Institute of Sports Medicine, Shandong First Medical University & Shandong Academy Medical Sciences, Shandong
• State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

CZECH REPUBLIC

• Faculty of Medicine and Dentistry, Palacký University Olomouc

DENMARK

• Novo Nordisk A/S

FRANCE

• Genethon
• Claude Bernard University, Lyon
• IMS Laboratory, University of Bordeaux
• Department of Biology, University of Le Havre

GERMANY

• Bayer A/G
• Evotec International GmbH, Göttingen
• Institute of Phycology, University of Regensburg
• Centre for Biological Signalling Studies, University Hospital Freiburg
• GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt
• Light Microscopy Facility, German Cancer Research Center (DKFZ)
• Department Physiology and Pathology of Ion Transport, Leibniz-Institut für Molekulare Pharmakologie

HUNGARY

• Avidin Biotechnology
• The Research Institute of Technical Physics and Materials Science
• Department of Genetics, Cell- and Immunobiology, Semmelweis University

ISRAEL

• Israel Institute for Biological Research (IIBR)
• Diabetes Research Center, The Hebrew University of Jerusalem
• Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva
• Raymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv

ITALY

• Institute of Biophysics, National Research Council of Italy, Genoa
• Department of Civil Engineering and Architecture, University of Pavia

JAPAN

• Laboratory of Biomaterials, Kyoto University, Kyoto
• Division of Oral Bioengineering, Niigata University, Niigata
• Department of Molecular Medicine and Biochemistry, Akita University
• Faculty of Pharmacy Advanced Biomedical Products, Kindai University
• Department of Biochemistry and Molecular Biology, Kobe University, Kobe
• Center for Stem Cell Biology and Regenerative Medicine, University of Tokyo

KOREA

• Division of Life Sciences, Korea University, Seoul
• Chemical Biology Research Center, Korea Research Inst. of Bioscience and Biotechnology (KRIBB)

LITHUANIA

• Lithuanian Center for Innovative Medicine

MALAYSIA

• Institute for Research in Molecular Medicine, Universiti Sains Malaysia

NETHERLANDS

• Biophysical chemistry, Radboud University

NEW ZEALAND

• University of Auckland, Auckland

NORWAY

• Institute of Clinical Medicine, University of Oslo
• Department of Biomedicine, University of Bergen

POLAND

• Institute of Medical Biology, Polish Academy of Sciences, Lodz
• Department of Physiology, Pomeranian Medical University in Szczecin
• Department of Microbiology and Immunology, Medical University of Silesia
• Department of Biology and Pharmaceutical Botany, Medical University of Gdańsk
• Department of Clinical Immunology, Jagiellonian University Medical College, Krakow

RUSSIA

• InnovaBio

SINGAPORE

• Esco Micro Pte. Ltd.

SWEDEN

• Fluicell AB
• Cline Scientific AB
• Solid State Physics, Lund University
• Health and Society, Malmö University
• Department of Biology, Lund University
• Sahlgrenska University Hospital, Gothenburg
• Department of Molecular Biology, Umeå University
• Clinical Chemistry and Pharmacology, Lund University
• Department of Experimental Medical Science, Lund University
• Nursing and Medical Technology, Luleå University of Technology
• Sahlgrenska Center for Cancer Research, University of Gothenburg

SWITZERLAND

• University of Fribourg

TAIWAN

• Institute of Biomedical Sciences, Academia Sinica, Taipei
• Laboratory Animal Center, Taipei Medical University, Taipei
• Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan
• Graduate Institution of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City

TURKEY

• Department of Biochemistry, Ege University
• Department of Biochemistry, Dumlupınar University

UK

• University of Aberdeen
• Imperial College, London
• St James´s University Hospital, Leeds
• Bristol Medical School, University of Bristol
• Institute of Aquaculture, University of Stirling
• School of Engineering, University of Glasgow
• Department of Chemical Engineering, Loughborough University
• MRC Centre for Regenerative Medicine, The University of Edinburgh
• Institute of Infection, Immunity & Inflammation, University of Glasgow
• School of Health and Life Sciences, University of West Scotland, Glasgow
• Healthcare Science Research Institute, Manchester Metropolitan University

US

• Artemys Foods
• Gladstone Institutes
• Pandorum Technology
• Johns Hopkins University
• Penn State College of Medicine
• Biological Sciences, San Jose State University
• Huntsman Cancer Institute, University of Utah
• OHNS/Otology & Neurotology, Stanford University
• Pharmaceutical Sciences, Northeastern University
• School of Pharmacy, North Dakota State University
• Vascular Biology Program, Boston Children’s Hospital
• Bioengineering, University of Massachusetts Dartmouth
• National Institute on Aging, National Institutes of Health
• Harvard Medical School, Partners HealthCare International
• Wake Forest Institute of Regenerative Medicine, Winston-Salem
• Cell Biology and Human Anatomy, University of California, Davis
• Department of Ophthalmology and Visual Sciences, University of Iowa
• Cardiovascular Research Institute, University of California, San Francisco